ABSTRACT:
In the present study, Repaglinide an anti-diabetic drug is formulated in the form of floating mucoadhesive tablets to improve its bioavailability. Hydroxy Propyl Methyl Cellulose K200M, Sodium Carboxy Methyl Cellulose, Carbopol 974P, Karaya gum, Chitosan, Xanthan gum were used as rate controlling and mucoadhesive polymers in designing the tablets.Various formulations were prepared by using different concentration of polymers. The pre-compression blend of Repaglinide mucoadhesive tablets were characterized with respect to angle of repose, bulk density, tapped density, carr’s index and hausner’s ratio and all the results indicated that the blend had good flow property and better compressibility.The swelling studies were performed and the results indicated that all the formulations had good swelling index. The results of floating lag time and buoyancy studies suggested that formulations had good floating ability. The drug release studies indicated a controlled and enhanced drug release for a period of 12hrs. In-vivo study was carried out using the optimized formulation.Based on the in-vitro drug release and other related evaluation tests, formulation RT11 containing drug: karaya gum in the ratio 1:2 was optimized. The drug release of the formulation RT11 followed Higuchi model with regression value of 0.984.
Cite this article:
Dharmajit Pattanayak, Jagdish K Arun, Ramesh Adepu, B. Shrivastava, C.M Hossain, Saumya Das. Formulation and Evaluation of Floating and Mucoadhesive Tablets containing Repaglinide. Research J. Pharm. and Tech 2020; 13(3):1277-1284. doi: 10.5958/0974-360X.2020.00235.8
Cite(Electronic):
Dharmajit Pattanayak, Jagdish K Arun, Ramesh Adepu, B. Shrivastava, C.M Hossain, Saumya Das. Formulation and Evaluation of Floating and Mucoadhesive Tablets containing Repaglinide. Research J. Pharm. and Tech 2020; 13(3):1277-1284. doi: 10.5958/0974-360X.2020.00235.8 Available on: https://rjptonline.org/AbstractView.aspx?PID=2020-13-3-40
REFERENCES:
1. Shaikh Siraj, Dr. Molvi Khurshid. I. Current Trends in
Gastroretentive Floating-Bioadhesive Drug Delivery System. 25 April 2016.
2. N. Rouge, P. Buri, E. Doelker, Drug absorption sites
in the gastrointestinal tract and dosage forms for site specific. Delivery,
Int. J. Pharm. (1996): 136; 117–139
3. Alexander Streube, Juergen Siepmann and Roland
Bodmeier. Drug delivery to the upper small intestine window using gastro
retentive technologies. Current Opinion in Pharmacology 2006: 6:501–508.
4. AV Mayavanshi and SS Gajjar
Floating drug delivery systems to increase gastric retention of drugs: A Review Research J. Pharm. and
Tech. 1(4): Oct.-Dec. 2008.
5. Dharmajit Pattanayak et
al., A systemic review on Floating
Mucoadhesive Drug Delivery System, Indo Am. J. P. Sci, 2018; 05(04).
6. Vipul D. Prajapati et. al, Raft forming system An
upcoming approach of gastroretentive drug delivery system, Journal of Controlled
Release 2013: 168; 151–165.
7. P.L. Bardonnet , V. Faivre , W.J. Pugh , J.C.
Piffaretti , F. Falson . Gastro retentive dosage forms: Overview and special
case of Helicobacter pylori Journal of Controlled Release 2006: 11;11 – 18.
8. G. Eswer, M. Saritha. Formulation and Evaluation of
Atenolol Floating Tablets Using Different Polymers:Guargum, Sodium Alginate,
Hpmc100cps and Carbopol940. International Journal of Pharmaceutical and
Biological Archives 2011: 2(4);1146-1151.
9. Komuravellysomeshwar, Kalyanichithaluru, Tadikondaramarao,
K. K. Kalyankumar. Formulation and evaluation of effervescent floating tablets
of tizanidine hydrochloride. Acta Pharm. 2011:61; 217–226.
10. Gupta Rishikesh, Prajapati
SK, Bhardwaj P and Chaurasia H,In-Vivo
Evaluation of Glipizide Floating Micropheres, Research J. Pharm. and
Tech.2 (3): July-Sept. 2009.
11. Pradip P Gade, Mohd.
MajidIqbal and K Sreenivasa Rao Development and In-Vitro Evaluation of
Gastro-Retentive Floating Drug Delivery System of CefiximeTrihydrate Research J. Pharm. and
Tech.2 (3): July-Sept. 2009
12. Varma MM, Suneetha S and
Raju DB Design and Evaluation of Floating Drug Delivery System of Furosemide Research J. Pharm. and
Tech. 3(2): April- June 2010.
13. Rajashree S. Masareddy, Smitha
D. Rananaware and Bhushan R. Patil Preparation and Characterization of
Rabeprazole Gastroretentive Drug Delivery System by Ionotropic Gelation
Technique,
Research J. Pharm. and Tech. 3(2): April- June 2010; Page 526-529.
14. Banker GS, Rhodes CT. Modern Pharmaceutics. Sustained
and Controlled Release Delivery Systems. Marcel Dekker. 2002: 4th;501-528.
15. Himabindu Peddapalli, Vasudha
Bakshi, Narender Boggula Formulation, in vitro and ex vivo characterization of
mucoadhesive buccal tablets for antihypertensive drug
Asian J Pharm Clin, 2018: 11 (8); 402-411
16. Mahesh Hemnani, Upendra Patel,
Ghanshyam Patel, Dhiren Daslaniya, Amarish Shah. Matrix tablets: A Tool Of
Controlled Drug Delivery. American Journal Of Pharmatech Research. 2011: 1(4); 2249-3387.
17. Sahel M, Al-Saidan, Krishnaiah YSR, Satyanarayana V.
In-Vitro And In-Vivo Evaluation Of Guargum Matrix Tablets For Oral Controlled
Release Of Water-Soluble Diltiazem Hydrochloride. AAPS Pharm. Sci.Tech. 2005:
6(1);31-36.
18. Anas T. Alhamdany, Ali Khidher Abbas, formulation and In
vitro evaluation of Amlodipine gastroretentive floating tablets using a combination
of hydrophilic and hydrophobic polymers, Int J App Pharm, 2018:10(6); 126-134
19. Ali Nokhodchi, Shaista Raja,
Priya Patel, Kofi Asare-Addo. The Role Of Oral Controlled Release Matrix
Tablets In Drug Delivery Systems. Bioimpacts.2012:2(4);175-187.
20. Tom Damien, Someshwara Rao
B., Ashok Kumar P., Amith S.
Yadav and Suresh V. Kuikarni Formulation and Evaluation Theophylline Floating
Tablets and the Effect of Citric Acid on Release Research J. Pharm. and Tech.3 (4): Oct.-Dec.2010; Page 1066-1071.
21. S. Gopalakrishnan and A.
Chenthilnathan, Formulation and In
Vitro evaluation of Aceclofenac oral floating tablets, Research J. Pharm. and
Tech. 4(4): April 2011.
22. Das Saumya, Pattanayak Dharmajit formulation and optimization of gastro
retentive drug delivery system containing Glipizide; Int
J Pharm Pharm Sci, Vol 4, Issue 1, 203-205.
23. S. Vijaya Kumar, Manoj Kumar
Deka, Manish Bagga, M. Sasi Kala and Guru Sharan, A Systematic Review on
Floating Drug Delivery System Research J. Pharm. and Tech. 4(1): January 2011
24. Vyas SP, Khar RK. Controlled
Drug Delivery Concepts and Advances. CBS Publishers, 2001:1;1-53.
25. Abdul Sayeed, Sheshgiri Gada
and Mallikarjun B. Kinagi; Formulation and Development of Gastric Floating Drug
Delivery Systems of Simvastatin Research J. Pharm. and Tech. 3(4): Oct.-Dec. 2010.
26. Ankit A. Kharia, S.N.
Hiremath, A.K. Singhai, L.K. Omray and G.R Godge; Formulation Strategy for Low
Absorption Window Antihypertensive Agent, Research J. Pharm. and Tech. 3(1): Jan.-Mar. 2010
27. Bramhanker DM, Jaiswal SB.
Controlled Release Medications. Biopharmaceutics And Pharmacokinetics a
Treatise. Vallabh Prakashan, 1995: 2;335-375.
28. Peppas NA. Analysis Of Fickian
And Non-Fickian Drug Release From Polymers. Pharm. Acta. Helv 1985:
60(4);110-111.
29. Korsmeyer RW, Gurny R, Doelker E, Peppas NA. Mechanism
Of Solute Release FromPorous Hydrophilic Polymers. Int. J. Pharm. 1983:15;25-35.
30. Hixon AW, Crowell JH. Dependence Of Reaction Velocity
Upon Surface And Agitation,I- Theoretical Consideration. Ind. Eng. Chem.
1931:23; 923-931.
31. Jang-wooshin, In-chanseol,
Chang-gueson. Interpretation of animal dose and
human
equivalent dose
for drug development. TheJournal of
Korean Oriental Medicine
2010:31(3);1-7